Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

Analyst Jeffrey Hung of Morgan Stanley maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), retaining the price target ...

Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...

PTC Therapeutics (PTCT) reported $196.79 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 0.1%. EPS of -$1.39 for the same period compares to -$1.76 a ...

The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...

PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share.

The fund owned 3,949 shares of the technology company’s stock after buying an additional 2,204 shares during the period. Mount Yale Investment Advisors LLC’s holdings in PTC were worth $ ...

The company will provide sales and support for the following Teledyne Marine product lines:High-resolution multibeam sonar systems for hydrographic and oceanographic surveys.Data acquisition and ...

Bain & Company's consultants provide management advice from 64 offices in 39 countries. Founded in 1973 in Boston, Bain & Co. has evolved into one of the big three management-consulting firms ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...